Nicole Miller

Nicole Miller, PhD is the Vice President of Molecular Diagnostics at Ultragenyx, a patient-focused biotech company led by Emil Kakkis that develops therapies for rare genetic disease. She focuses on advancing biochemical and genetic testing in support of reducing the diagnostic odyssey for rare disease patients. She has partnered to develop and launch ten gene locus specific databases and published several variant reviews for rare genetic disorders.  Prior to Ultragenyx, Nicole developed and led a similar function at BioMarin for about 9 years, focusing on rare disease patient diagnosis. Since 2010, Nicole has worked closely with the newborn screening and sequencing community in support of improving newborn screening for rare disease.  Prior to working in the rare disease field, she led a molecular pharmacology research team at Exelixis and led a biomarker program there for about a decade supporting research through clinical development. Nicole has a bachelor’s degree in genetics from U.C. Davis, a PhD in oncology from U.W. Madison and her postdoc was at UCSF. She sits on the board of the Professional Science Master’s program at the University of San Francisco since the program’s inception.